How does Rentokil make money?
Repligen Corporation operates as a life sciences bioprocessing company, generating its revenue by developing, manufacturing, and commercializing highly specialized bioprocessing technologies utilized by pharmaceutical and biotechnology developers. The company makes money by selling consumable products, filtration systems, chromatography equipment, and analytical instruments used directly in the large-scale production of biological drugs, monoclonal antibodies, and gene therapies. Its business model relies on direct B2B sales to drug manufacturers, securing critical design inclusions during clinical trial phases, and supplying high-margin filtration and protein-handling tools required throughout commercial biopharmaceutical manufacturing lifecycles.
Related FAQs
BlackRock does not own Roche Holding AG, a publicly traded company with a diverse ownership base.
Yes, Sonic Automotive (trading under the ticker SAH) has experienced a substantial overall increase in its stock price over extended market horizons, reflecting solid financial growth as a premier automotive retailer and dealership network operato...
Andy Sieg, heading wealth management divisions at major financial institutions like Citi, commands elite executive compensation packages reflecting top-tier leadership in global wealth management.
Executive compensation for the Chief Executive Officer of Reinsurance Group of America (RGA)—a leading global life and health reinsurance enterprise—reflects institutional financial services benchmarks.
As of the close of the trading session on July 24, 2026, Revvity Inc (RVTY) stock was priced at $110.47 per share.